Empiriko
Curated by SignalBiomimetic organ-on-chip platform for drug discovery
Overview
Empiriko develops biomimetic organ-on-chip platforms for drug discovery. Its proprietary Biomimiks is a chemosynthetic liver that uses catalysts, biological process and computational modeling to mimic the liver's oxidative functions. This can then be used to predict drug metabolic profiles and potential toxicity in preclinical studies.
Key facts
- Founded
- 2010
- Headquarters
- Newton, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view